Abstract
Background
Calcitonin gene-related peptide (CGRP) is a powerful neuropeptide that is strongly involved in headache pain pathogenesis by triggering vasodilation, mast cell degranulation and neurogenic inflammation. This evidence has prompted us to investigate the acute influence of endurance exercise on CGRP concentration in blood.
Methods
The study population consisted of 48 male amateur runners, who ran a half-marathon distance at 75%–85% of maximal oxygen uptake. Blood was drawn before the run (pre-run) and immediately after each runner ended his trial (post-run). The serum concentration of CGRP was measured with a commercial enzyme-linked immunosorbent assay (ELISA) technique.
Results
Overall, 22/48 subjects (45.8%) reported suffering from headache, three of whom (6.2%) had an exertional headache, whilst 26/48 (54.2%) subjects did not report at least one headache episode during the previous 6 months (i.e. headache-free). All 48 athletes successfully covered the 21.1 km distance. Serum concentration of CGRP significantly increased by 1.5-fold in the entire group, as well as in the headache-positive and headache-free cohorts. Univariate Spearman’s correlation revealed that post-run variation of serum CGRP was significantly and inversely associated with running time (r = −0.30; p = 0.036).
Conclusions
The serum concentration of CGRP is significantly enhanced by medium-distance endurance exercise and the post-exercise increase is dependent on running intensity. Accordingly, high-exercise intensity might be directly related to triggering both exertional headache and/or migraine episodes.
Acknowledgments
Fabian Sanchis-Gomar is supported by a postdoctoral contract granted by “Subprograma Atracció de Talent – Contractes Postdoctorals de la Universitat de València”.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Collaborators GBDH. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018;17:954–76.10.1016/S1474-4422(18)30322-3Search in Google Scholar
2. Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache 2015;55:21–34.10.1111/head.12482Search in Google Scholar PubMed
3. Amin FM, Aristeidou S, Baraldi C, Czapinska-Ciepiela EK, Ariadni DD, Di Lenola D, et al. The association between migraine and physical exercise. J Headache Pain 2018;19:83.10.1186/s10194-018-0902-ySearch in Google Scholar PubMed PubMed Central
4. Ahn AH. Why does increased exercise decrease migraine? Curr Pain Headache Rep 2013;17:379.10.1007/s11916-013-0379-ySearch in Google Scholar PubMed PubMed Central
5. Lippi G, Mattiuzzi C, Sanchis-Gomar F. Physical exercise and migraine: for or against? Ann Transl Med 2018;6:181.10.21037/atm.2018.04.15Search in Google Scholar PubMed PubMed Central
6. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1–211.10.1177/0333102417738202Search in Google Scholar PubMed
7. Hanashiro S, Takazawa T, Kawase Y, Ikeda K. Prevalence and clinical hallmarks of primary exercise headache in middle-aged Japanese on health check-up. Intern Med 2015;54:2577–81.10.2169/internalmedicine.54.4926Search in Google Scholar PubMed
8. Tofangchiha S, Rabiee B, Mehrabi F. A study of exertional headache’s prevalence and characteristics among conscripts. Asian J Sports Med 2016;7:e30720.10.5812/asjsm.30720Search in Google Scholar PubMed PubMed Central
9. Chen SP, Fuh JL, Lu SR, Wang SJ. Exertional headache – a survey of 1963 adolescents. Cephalalgia 2009;29:401–7.10.1111/j.1468-2982.2008.01744.xSearch in Google Scholar PubMed
10. Edvinsson L, Warfvinge K. Recognizing the role of CGRP and CGRP receptors in migraine and its treatment. Cephalalgia 2019;39:366–73.10.1177/0333102417736900Search in Google Scholar PubMed
11. Khan S, Olesen A, Ashina M. CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data. Cephalalgia 2019;39:374–89.10.1177/0333102417741297Search in Google Scholar PubMed
12. Snoer A, Vollesen AL, Beske RP, Guo S, Hoffmann J, Fahrenkrug J, et al. Calcitonin-gene related peptide and disease activity in cluster headache. Cephalalgia 2019;39:575–84.10.1177/0333102419837154Search in Google Scholar PubMed
13. Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies – successful translation from bench to clinic. Nat Rev Neurol 2018;14:338–50.10.1038/s41582-018-0003-1Search in Google Scholar PubMed
14. Edvinsson L. Role of CGRP in migraine. Handb Exp Pharmacol 2019;255:121–30.10.1007/164_2018_201Search in Google Scholar PubMed
15. Lippi G, Schena F. Run for Science (R4S): the history of a successful project of precision and laboratory medicine in sport and exercise. J Lab Precis Med 2017;2:11.10.21037/jlpm.2017.04.01Search in Google Scholar
16. Koppen H, van Veldhoven PL. Migraineurs with exercise-triggered attacks have a distinct migraine. J Headache Pain 2013;14:99.10.1186/1129-2377-14-99Search in Google Scholar PubMed PubMed Central
17. Sandoe CH, Kingston W. Exercise headache: a review. Curr Neurol Neurosci Rep 2018;18:28.10.1007/s11910-018-0840-8Search in Google Scholar PubMed
18. Tepper SJ. History and review of anti-calcitonin gene-related peptide (CGRP) therapies: from translational research to treatment. Headache 2018;58(Suppl 3):238–75.10.1111/head.13379Search in Google Scholar PubMed
19. Wyon Y, Hammar M, Theodorsson E, Lundeberg T. Effects of physical activity and acupuncture on calcitonin gene-related peptide immunoreactivity in different parts of the rat brain and in cerebrospinal fluid, serum and urine. Acta Physiol Scand 1998;162:517–22.10.1046/j.1365-201X.1998.0317e.xSearch in Google Scholar PubMed
20. Parnow A, Gharakhanlou R, Gorginkaraji Z, Rajabi S, Eslami R, Hedayati M, et al. Effects of endurance and resistance training on calcitonin gene-related peptide and acetylcholine receptor at slow and fast twitch skeletal muscles and sciatic nerve in male wistar rats. Int J Pept 2012;2012:962651.10.1155/2012/962651Search in Google Scholar PubMed PubMed Central
21. Parnow AH, Gharakhanlou R, Eslami R. Effects of physical activity on calcitonin gene-related peptide content at trigeminal ganglion nerve in wistar rats. J Mazand Univ Med Sci 2012;22:25–31.10.1155/2012/962651Search in Google Scholar
22. Jonhagen S, Ackermann P, Saartok T, Renstrom PA. Calcitonin gene related peptide and neuropeptide Y in skeletal muscle after eccentric exercise: a microdialysis study. Br J Sports Med 2006;40:264–7; discussion 264–7.10.1136/bjsm.2005.022731Search in Google Scholar PubMed PubMed Central
23. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 1994;117(Pt 3): 427–34.10.1093/brain/117.3.427Search in Google Scholar PubMed
24. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48–56.10.1002/ana.410330109Search in Google Scholar PubMed
©2020 Walter de Gruyter GmbH, Berlin/Boston
